Announcement of Hubei Jichuan Pharmaceutical Co., Ltd. on the adjustment of the strategy committee of the company's board of directors to the strategy and ESG committee of the board of directors and the revision of relevant systems
Securities code: 600566 Securities abbreviation: Jichuan Pharmaceutical Announcement number: 2026-030
Hubei Jichuan Pharmaceutical Co., Ltd.
Regarding the adjustment of the strategy committee of the company's board of directors to the strategy and strategy committee of the board of directors
Announcement of the ESG Committee and revision of relevant systems
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.
Hubei Jichuan Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") held the 20th meeting of the 10th board of directors on April 23, 2026, and reviewed and approved the "Proposal on Adjusting the Strategy Committee of the Company's Board of Directors to the Strategy and ESG Committee of the Board of Directors and Revising Related Systems". The relevant information is hereby announced as follows:
In order to further improve the corporate governance structure, improve the company's environmental, social and corporate governance (ESG) management level, and enhance the company's sustainable development capabilities, in accordance with the "Company Law of the People's Republic of China", "Listed Company Governance Code", "Shanghai Stock Exchange Self-Regulatory Supervision Guidelines for Listed Companies No. 1 - Standardized Operations", "Shanghai Stock Exchange Self-Regulatory Supervision Guidelines for Listed Companies No. 14 - Sustainability Report (Trial)" and other relevant laws, regulations and normative documents as well as the relevant provisions of the "Articles of Association", the company plans to make the following adjustments to the Strategy Committee of the Board of Directors:
Adjust the "Board Strategy Committee", a special committee under the board of directors, to the "Board Strategy and ESG Committee", and add ESG-related responsibilities to the original responsibilities of the strategy committee;
Revise the original "Working Rules of the Board of Directors Strategy Committee" to the "Working Rules of the Board of Directors Strategy and ESG Committee";
For details of the revised working rules, please refer to the "Working Rules of the Strategy and ESG Committee of the Board of Directors of Hubei Jichuan Pharmaceutical Co., Ltd." disclosed on the Shanghai Stock Exchange website (www.sse.com.cn).
Announcement is hereby made.
Hubei Jichuan Pharmaceutical Co., Ltd.
board of directors
April 24, 2026